Literature DB >> 18187693

Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus.

Tracy R McMillan1, Bethany B Moore, Jason B Weinberg, Kevin M Vannella, W Brad Fields, Paul J Christensen, Linda F van Dyk, Galen B Toews.   

Abstract

RATIONALE: Idiopathic pulmonary fibrosis is a progressive disease with high mortality. Although most patients have a slow, progressive course, some patients will have an acute deterioration in function or acute exacerbation, which carries a poor prognosis. In some cases, acute deterioration is associated with infection. Herpesviruses have been associated with this disease. Fibrocytes have also been shown to be important in the pathogenesis of pulmonary fibrosis.
OBJECTIVES: To develop a murine model for infectious exacerbation of preexisting fibrosis, and provide mechanistic insight into the role of herpesviruses in fibrotic disease.
METHODS: We used a model of fluorescein isothiocyanate-induced pulmonary fibrosis in mice. Infection with a murine gammaherpesvirus was given at time of established lung fibrosis. Measurements were made at the time of peak lytic viral replication.
MEASUREMENTS AND MAIN RESULTS: We demonstrate that infection with gammaherpesvirus can exacerbate established fluorescein isothiocyanate-induced fibrosis evidenced by increased total lung collagen, histologic changes of acute lung injury, and diminished lung function. Gammaherpesvirus can exacerbate preexisting fibrosis in a Th1 cytokine environment and in the absence of Th2 cytokines. Gammaherpesvirus increases fibrocyte recruitment to the lung in wild-type, but not CCR2(-/-) mice, in part because viral infection up-regulates production of CCL2 and CCL12, chemokines important for fibrocyte recruitment. In contrast, mouse adenovirus infection did not exacerbate collagen deposition.
CONCLUSIONS: These data provide a new model for gammaherpesvirus exacerbation of established pulmonary fibrosis. The up-regulation of chemokines during viral infection and subsequent recruitment of fibrocytes to the lung likely contribute to augmentation of pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187693      PMCID: PMC2277211          DOI: 10.1164/rccm.200708-1184OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  47 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.

Authors:  R Abe; S C Donnelly; T Peng; R Bucala; C N Metz
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

3.  Attenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12.

Authors:  T Maeyama; K Kuwano; M Kawasaki; R Kunitake; N Hagimoto; N Hara
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

4.  Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin.

Authors:  E S Chen; B M Greenlee; M Wills-Karp; D R Moller
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

5.  Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice.

Authors:  B Ebrahimi; B M Dutia; D G Brownstein; A A Nash
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

6.  Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure.

Authors:  J B Stern; H Mal; O Groussard; O Brugière; A Marceau; G Jebrak; M Fournier
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

7.  Type 1/type 2 cytokine paradigm and the progression of pulmonary fibrosis.

Authors:  N W Lukacs; C Hogaboam; S W Chensue; K Blease; S L Kunkel
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

8.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure.

Authors:  S Blivet; F Philit; J M Sab; B Langevin; M Paret; C Guérin; D Robert
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

9.  The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection.

Authors:  G B Huffnagle; R M Strieter; T J Standiford; R A McDonald; M D Burdick; S L Kunkel; G B Toews
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

10.  Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice.

Authors:  Ana L Mora; Edilson Torres-González; Mauricio Rojas; Jianguo Xu; Jeffrey Ritzenthaler; Samuel H Speck; Jesse Roman; Kenneth Brigham; Arlene Stecenko
Journal:  Am J Respir Crit Care Med       Date:  2007-03-15       Impact factor: 21.405

View more
  56 in total

Review 1.  Fibrosis: ultimate and proximate causes.

Authors:  Victor J Thannickal; Yong Zhou; Amit Gaggar; Steven R Duncan
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.

Authors:  Payal N Naik; Jeffrey C Horowitz; Thomas A Moore; Carol A Wilke; Galen B Toews; Bethany B Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-21       Impact factor: 6.053

3.  Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; William E Lawson; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-16       Impact factor: 5.464

4.  Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Authors:  Daniela Damjanovic; Maziar Divangahi; Kapilan Kugathasan; Cherrie-Lee Small; Anna Zganiacz; Earl G Brown; Cory M Hogaboam; Jack Gauldie; Zhou Xing
Journal:  Am J Pathol       Date:  2011-10-14       Impact factor: 4.307

5.  Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.

Authors:  Joshua S Stoolman; Kevin M Vannella; Stephanie M Coomes; Carol A Wilke; Thomas H Sisson; Galen B Toews; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

6.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Kazuhisa Konishi; Kevin F Gibson; Kathleen O Lindell; Thomas J Richards; Yingze Zhang; Rajiv Dhir; Michelle Bisceglia; Sebastien Gilbert; Samuel A Yousem; Jin Woo Song; Dong Soon Kim; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2009-04-10       Impact factor: 21.405

7.  Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

Authors:  MeiLan K Han; Yueren Zhou; Susan Murray; Nabihah Tayob; Imre Noth; Vibha N Lama; Bethany B Moore; Eric S White; Kevin R Flaherty; Gary B Huffnagle; Fernando J Martinez
Journal:  Lancet Respir Med       Date:  2014-04-21       Impact factor: 30.700

8.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

Review 9.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

10.  Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide.

Authors:  Elizabeth A Turpin; Aurita Antao-Menezes; Mark F Cesta; James B Mangum; Duncan G Wallace; Edilberto Bermudez; James C Bonner
Journal:  Respir Res       Date:  2010-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.